Alberto Casellas - 17 Feb 2026 Form 4 Insider Report for Synchrony Financial (SYF)

Reporting relationship: EVP, CEO--Health & Wellness
Issuer ticker: SYF
Reported as of: 17 Feb 2026
Net transaction value: -$2,717,114
SEC form: 4
Accepted by SEC: 19 Feb 2026, 16:04:52 UTC
Prior SEC filing: 23 Jan 2026
Next SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Danielle Do as attorney in fact

Key filing fact

Alberto Casellas filed Form 4 for Synchrony Financial (SYF) on 19 Feb 2026.

Key facts

This page summarizes Alberto Casellas's Form 4 filing for Synchrony Financial (SYF).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 19 Feb 2026, 16:04.

Change

Previous filing in this sequence was filed on 23 Jan 2026.
Current net transaction value: -$2,717,114.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001763554 Primary reporting owner

Casellas Alberto

Relationship: EVP, CEO--Health & Wellness
Address: 777 LONG RIDGE ROAD, C/O CORPORATE SECRETARY, STAMFORD
Signature: /s/ Danielle Do as attorney in fact
Signature date: 19 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SYF transaction

Dividend Equivalent Unit

Award

Transaction value: $15,040
Shares: +208
Change %: +0.22%
Price: $72.31
Shares after: 93,058
Date: 17 Feb 2026
Ownership: Direct
Footnotes: F1

SYF transaction

Common Stock

Options Exercise

Transaction value: $198,734
Shares: +5,794
Change %: +6.2%
Price: $34.30
Shares after: 98,852
Date: 17 Feb 2026
Ownership: Direct
Footnotes: F2

SYF transaction

Common Stock

Sale

Transaction value: $2,930,888
Shares: -41,514
Change %: -42%
Price: $70.60
Shares after: 57,338
Date: 17 Feb 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SYF transaction Derivative

Phantom Stock Units

Award

Transaction value: $0
Shares: +1
Change %: +0.41%
Price: $0.000000
Shares after: 185
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1
Exercise price
Footnotes: F3

SYF transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -5,794
Change %: -50%
Price: $0.000000
Shares after: 5,794
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,794
Exercise price: $34.30
Footnotes: F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Represents dividend equivalent units accrued on February 17, 2026 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

Footnote F2

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 27, 2025.

Footnote F3

The reported phantom stock units were acquired pursuant to a dividend reinvestment feature under the Synchrony Financial Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled, in cash, six months following the Reporting Person's separation from service to the Company, subject to the requirements set forth in the Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of Synchrony Financial common stock.

Footnote F4

The reporting person was awarded 11,588 employee stock options on April 1, 2017, which vested in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.

SEC remarks

EVP, CEO--Health & Wellness